EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin‐induced demyelination in mice

Ross van de Wetering iD, Rabia Bibi, Andy Biggerstaff, Sheein Hong, Bria Pengelly, Thomas E Prisinzano iD, Anne C La Flamme iD, Bronwyn M Kivell iD

Glia · 2024

DOI: 10.1002/glia.24583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glia, 2024. Verfasst von Ross van de Wetering und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Centre for Biodiscovery, Victoria University of Wellington, Wellington, New Zealand. Hauptthemen laut MEDLINE: Morphinans, Mice, Inbred C57BL, Spiro Compounds, Demyelinating Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, Health Research Council of New Zealand, Victoria University of Wellington.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The kappa opioid receptor has been identified as a promising therapeutic target for promoting remyelination. In the current study, we evaluated the ability of nalfurafine to promote oligodendrocyte progenitor cell (OPC) differentiation and myelination in vitro , and its efficacy in an extended, cuprizone‐induced demyelination model. Primary mouse (C57BL/6J) OPC‐containing cultures were treated with nalfurafine (0.6–200 nM), clemastine (0.01–100 μM), T3 (30 ng/mL), or vehicle for 5 days. Using immunocytochemistry and confocal microscopy, we found that nalfurafine treatment increased OPC differentiation, oligodendrocyte (OL) morphological complexity, and myelination of nanofibers in vitro . Adult male mice (C57BL/6J) were given a diet containing 0.2% cuprizone and administered rapamycin (10 mg/kg) once daily for 12 weeks followed by 6 weeks of treatment with nalfurafine (0.01 or 0.1 mg/kg), clemastine (10 mg/kg), or vehicle. We quantified the number of OLs using immunofluorescence, gross myelination using black gold staining, and myelin thickness using electron microscopy. Cuprizone + rapamycin treatment produced extensive demyelination and was accompanied by a loss of mature OLs, which was partially reversed by therapeutic administration of nalfurafine. We also assessed these mice for functional behavioral changes in open‐field, horizontal bar, and mouse motor skill sequence tests (complex wheel running). Cuprizone + rapamycin treatment resulted in hyperlocomotion, poorer horizontal bar scores, and less distance traveled on the running wheels. Partial recovery was observed on both the horizontal bar and complex running wheel tests over time, which was facilitated by nalfurafine treatment. Taken together, these data highlight the potential of nalfurafine as a remyelination‐promoting therapeutic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MorphinansMice, Inbred C57BLSpiro CompoundsDemyelinating DiseasesMyelin SheathSirolimusCuprizoneAnimalsMaleMiceCells, CulturedDisease Models, AnimalOligodendrocyte Precursor CellsCell Differentiation

Stichwörter der Autor:innen

cuprizonedifferentiationmultiple sclerosisnalfurafineoligodendrocyterapamycinremyelination

Substanzen

MorphinansSpiro CompoundsTRK 820SirolimusCuprizone

Autor:innen und Institutionen

  • School of Biological Sciences, Centre for Biodiscovery, Victoria University of Wellington, Wellington, New Zealand.
  • Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky, USA.
  • Malaghan Institute of Medical Research, Wellington, New Zealand.

ORCID-Profile: Ross van de Wetering, Thomas E Prisinzano, Anne C La Flamme, Bronwyn M Kivell

Förderung

  • NIDA NIH HHS
  • Health Research Council of New Zealand
  • Victoria University of Wellington
  • Neurological Foundation of New Zealand

Zitieren

APA

van de Wetering, R., Bibi, R., Biggerstaff, A., Hong, S., Pengelly, B., Prisinzano, T. E., La Flamme, A. C., & Kivell, B. M. (2024). Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin‐induced demyelination in mice. Glia. https://doi.org/10.1002/glia.24583

Vancouver

van de Wetering R, Bibi R, Biggerstaff A, Hong S, Pengelly B, Prisinzano TE, et al. Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin‐induced demyelination in mice. Glia. 2024. doi:10.1002/glia.24583

BibTeX
@article{vandeWetering2024,
  author = {van de Wetering, Ross and Bibi, Rabia and Biggerstaff, Andy and Hong, Sheein and Pengelly, Bria and Prisinzano, Thomas E and La Flamme, Anne C and Kivell, Bronwyn M},
  title = {Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin‐induced demyelination in mice},
  journal = {Glia},
  year = {2024},
  doi = {10.1002/glia.24583}
}
Kostenlos starten →